About MEMTAB
This international symposium attracts researchers, healthcare workers, policy makers and manufacturers actively involved in the development, evaluation or regulation of tests, (bio)markers, models, tools, apps, devices or any other modality used for the purpose of diagnosis, prognosis, risk stratification or (disease or therapy) monitoring. Rapid technological progress coupled with the significant methodological complexities involved in developing, evaluating and implementing tests, markers, models or devices create formidable challenges. Yet these challenges are matched by unique opportunities, while the wide array of involved subdisciplines create an exciting milieu for the generation of new ideas and directions.
This symposium provides a forum for disseminating knowledge at the forefront of current research, and for stimulating dialogue that will propel future thought and endeavours to tackle the methodological and practical complexities facing the medical diagnostic, prognostic and monitoring field today.
The 2020 event is specifically aimed at bringing together researchers from the diverse reaches of test evaluation, from in vitro test developers, industry and regulatory representatives, through methodologists, guideline developers and practising clinicians, in the hope of improving current understanding through knowledge exchange, and forging our diverse experiences and perspectives to delineate the future direction of diagnostic test research. In this respect, it is the only conference in the world that provides a platform dedicated to the investigation of medical tests, markers, models and other devices used for diagnosis prognosis and monitoring.
MEMTAB2020 is financially supported by:
